U.S. flag

An official website of the United States government

NM_000525.4(KCNJ11):c.819C>T (p.Ser273=) AND Maturity-onset diabetes of the young type 13

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Apr 27, 2017
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001105475.5

Allele description [Variation Report for NM_000525.4(KCNJ11):c.819C>T (p.Ser273=)]

NM_000525.4(KCNJ11):c.819C>T (p.Ser273=)

Gene:
KCNJ11:potassium inwardly rectifying channel subfamily J member 11 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.1
Genomic location:
Preferred name:
NM_000525.4(KCNJ11):c.819C>T (p.Ser273=)
HGVS:
  • NC_000011.10:g.17387273G>A
  • NG_012446.1:g.6387C>T
  • NM_000525.4:c.819C>TMANE SELECT
  • NM_001166290.2:c.558C>T
  • NM_001377296.1:c.558C>T
  • NM_001377297.1:c.558C>T
  • NP_000516.3:p.Ser273=
  • NP_000516.3:p.Ser273=
  • NP_001159762.1:p.Ser186=
  • NP_001364225.1:p.Ser186=
  • NP_001364226.1:p.Ser186=
  • NC_000011.9:g.17408820G>A
  • NM_000525.3:c.819C>T
Links:
dbSNP: rs202238153
NCBI 1000 Genomes Browser:
rs202238153
Molecular consequence:
  • NM_000525.4:c.819C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001166290.2:c.558C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001377296.1:c.558C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001377297.1:c.558C>T - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Maturity-onset diabetes of the young type 13
Synonyms:
MODY, TYPE 13
Identifiers:
MONDO: MONDO:0014589; MedGen: C4225365; Orphanet: 552; OMIM: 616329

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001262443Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 13 December 2019)
Uncertain significance
(Apr 27, 2017)
germlineclinical testing

Citation Link,

SCV004698176Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
criteria provided, single submitter

(K And H Uppaluri Personalized Medicine Clinic Variant Classification And Assertion Criteria Updated V 2)
Likely benignunknownresearch

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedresearch

Citations

PubMed

KCNJ11: Genetic Polymorphisms and Risk of Diabetes Mellitus.

Haghvirdizadeh P, Mohamed Z, Abdullah NA, Haghvirdizadeh P, Haerian MS, Haerian BS.

J Diabetes Res. 2015;2015:908152. doi: 10.1155/2015/908152. Epub 2015 Sep 13. Review.

PubMed [citation]
PMID:
26448950
PMCID:
PMC4584059

KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.

Massa O, Iafusco D, D'Amato E, Gloyn AL, Hattersley AT, Pasquino B, Tonini G, Dammacco F, Zanette G, Meschi F, Porzio O, Bottazzo G, Crinó A, Lorini R, Cerutti F, Vanelli M, Barbetti F; Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology..

Hum Mutat. 2005 Jan;25(1):22-7.

PubMed [citation]
PMID:
15580558
See all PubMed Citations (5)

Details of each submission

From Illumina Laboratory Services, Illumina, SCV001262443.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic, SCV004698176.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (5)

Description

Potent mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which may be responsive to oral sulfonylureas. It is also associated with Neonatal Diabetes. However, no sufficient evidence is found to ascertain the role of this particular variant rs202238153 in MODY yet.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 16, 2024